When was Magellan Diagnostics founded?

Magellan Diagnostics was founded in 1968 and raised its 1st funding round 37 years after it was founded.

Where is Magellan Diagnostics located?

Magellan Diagnostics is headquartered in Billerica, United States.

Who is the current CEO of Magellan Diagnostics?

Amy Winslow of Magellan Diagnostics.

Is Magellan Diagnostics a funded company?

Magellan Diagnostics is a funded company, having raised a total of $34M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 21, 2005.

When was the latest funding round of Magellan Diagnostics?

Magellan Diagnostics' latest funding was a $***** Series C round on Nov 29, 2006, with participation from 7 investors.

Where does Magellan Diagnostics rank among its competitors?

Magellan Diagnostics ranks 1st amongst 4 active competitors, none of which are funded.

Who are the top competitors of Magellan Diagnostics?

Magellan Diagnostics' top competitors include Baseline Health, JT MeSh Diagnostics and Oligoscan. Among them, JT MeSh Diagnostics secured the most recent funding round in September, 2019.

Magellan Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Blood lead testing solutions to identify and protect those at risk. The company innovates lab solutions focused on human biology and interactions, bringing high-quality lab results to the point of care. They are dedicated to offering reliable products that help identify individuals at risk of harm due to lead exposure. Committed to educating clinicians, policymakers, families, and communities about the permanent health damage caused by lead, and the importance of prevention and detection. They design and build analyzers for the measurement of lead in blood, creating portable instruments for use outside traditional laboratories, broadening the accessibility of lead testing. Their mission is to help identify and protect those at risk through high-quality, reliable products.

Website: www.magellandx.com/
Social
Part Of

Key Metrics

Founded Year

1968

Location

Billerica, United States

Stage

Acquired

Total Funding

$34M in 3 rounds

Latest Funding Round

Series C, Nov 29, 2006, $*****

Investors

Abingworth & 9 more

Ranked

1^st among 4 active competitors

Similar Companies

Baseline Health & 4 more

Exit Details

Acquired by Meridian Bioscience (Mar 24, 2016)

View Magellan Diagnostics' full profile

Magellan Diagnostics got acquired by Meridian Bioscience on Mar 24, 2016 at an acquisition amount of $66M.

Click here to take a look at Magellan Diagnostics's acquisition in detail

Magellan Diagnostics has raised a total funding of $34M over 3 rounds. Its first funding round was on Mar 21, 2005. Its latest funding round was a Series C round on Nov 29, 2006 for $*****. 7 investors participated in its latest round. Magellan Diagnostics has 10 institutional investors.

Here is the list of recent funding rounds of Magellan Diagnostics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 29, 2006	2500012	Series C	3785018	9396217	8561228	9383840
Nov 29, 2006	9619945	Conventional Debt	5430037	8719040	9870255	NewStar Financial
Mar 21, 2005	1809933	Grant (prize money)	2378287	7269185	8797768	NIH

Access funding benchmarks and valuations. Sign up today!

View details of Magellan Diagnostics's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Magellan Diagnostics include Baseline Health, JT MeSh Diagnostics and Oligoscan. Here is the list of Top 10 competitors of Magellan Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Magellan Diagnostics 1968, Billerica (United States), Acquired	Blood lead testing solutions to identify and protect those at risk	$34M	Abingworth, KBL & 8 others	43/100
2nd	Baseline Health 2018, San Francisco (United States), Deadpooled	Provider of test kit for diagnosing body toxins	-	-	24/100
3rd	JT MeSh Diagnostics 2019, Philadelphia (United States), Funding Raised	Developer of breakthrough diagnostics for radiation exposure and organ transplant viability	-	HHS	22/100
4th	Oligoscan 2010, France, Unfunded	Developer of diagnostic device for the screening of physiological imbalances	-	-	16/100
5th	ToxTest 2011, Esslingen Am Neckar (Germany), Unfunded	Provider of a diagnostic test for heavy metal toxicity	-	-	16/100
6th	Beaufort Bar 2012, Burlington (United States), Deadpooled	Diagnostic tests for lead poisoning	-	-	15/100